| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 34 |
| 1 | ADALIMUMAB | 17 |
| 2 | ETANERCEPT | 16 |
| 3 | INFLIXIMAB | 15 |
| 4 | INTERFERON BETA-1A | 14 |
| 5 | METFORMIN | 10 |
| 6 | METFORMIN ER 500 MG | 10 |
| 7 | METFORMIN ER 750 MG | 10 |
| 8 | METHOTREXATE | 10 |
| 9 | METHOTREXATE SODIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 2 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 3 | ELIGLUSTAT | 1 | 0.0006 |
| 4 | TAMOXIFEN CITRATE | 3 | 0.0005 |
| 5 | PLECANATIDE | 1 | 0.0005 |
| 6 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 7 | SULINDAC | 1 | 0.0004 |
| 8 | ALENDRONATE SODIUM | 34 | 0.0003 |
| 9 | MARC GLASSMAN | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 34 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 2 | Integrin Receptor Antagonist [EPC] | 13 |
| 3 | Interferon beta [EPC] | 13 |
| 4 | Vitamin C [EPC] | 12 |
| 5 | Estrogen [EPC] | 10 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 7 | Corticosteroid [EPC] | 9 |
| 8 | Proton Pump Inhibitor [EPC] | 9 |
| 9 | Vitamin D [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 4 | Integrin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 5 | beta3-Adrenergic Agonist [EPC] | 4 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 7 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Interferon beta [EPC] | 13 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |